Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Lymphocytopenia as a Prognostic Marker for Diffuse Large B Cell Lymphoma

Date

Authors

Talaulikar, Dipti

Choudhury, Ayesha

Shadbolt, Bruce

Brown, Michael

Publisher

Informa Healthcare

Abstract

Lymphocytopenia has been reported to confer adverse outcomes in a number of hematological malignancies. Recently, it has been reported to be associated with poor outcome in diffuse large B-cell lymphoma (DLBCL). The aim of this study was to determine the

Keywords

Keywords: anthracycline; rituximab; adult; aged; article; B cell lymphoma; cancer chemotherapy; cancer palliative therapy; cancer staging; cancer survival; clinical assessment tool; correlational study; diffuse large b cell lymphoma; drug efficacy; female; human; i Diffuse large B cell lymphoma; International prognostic index; Lymphocytopenia; Non-Hodgkin lymphoma; Survival

URI

http://hdl.handle.net/1885/38564

Collections

ANU Research Publications

Source

Leukemia & Lymphoma

Type

Journal article

DOI

10.1080/10428190801959026

Restricted until

2037-12-31

Downloads

File

Description

01_Talaulikar_Lymphocytopenia_as_a_2008.pdf (214.8 KB)

02_Talaulikar_Lymphocytopenia_as_a_2008.pdf (74.65 KB)

abcd